← USPTO Patent Applications

INDOLINONE COMPOUNDS AND USES THEREOF

Application US20260076941A1 Kind: A1 Mar 19, 2026

Inventors

Jean-Michel Vernier

Abstract

Indolinone derivative compounds that act as EWS-PLI1 transcription factor inhibitors are provided. Also provided are pharmaceutical compositions of the indolinone derivatives, methods of synthesizing the same, methods of treating using same, and assays for identifying the inhibitors of EWS-FLI1 oncoprotein.

CPC Classifications

A61K 31/404 A61K 31/4155 A61K 31/4439 A61K 31/5377 C07D 209/34 C07D 209/38 C07D 401/06 C07D 401/10 C07D 403/10

Filing Date

2025-09-22

Application No.

19335663